Brazilian Pharmaceuticals & Biotech Potentially Undervalued Companies

Hypera

Market Cap: R$12.3b

Operates as a pharmaceutical company in Brazil.

Novo Nordisk

Market Cap: R$1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Teva Pharmaceutical Industries

Market Cap: R$15.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Regeneron Pharmaceuticals

Market Cap: R$59.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Bristol-Myers Squibb

Market Cap: R$103.2b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Gilead Sciences

Market Cap: R$129.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Merck

Market Cap: R$199.2b

Operates as a healthcare company worldwide.

Novartis

Market Cap: R$163.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

BeiGene

Market Cap: R$24.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Azenta

Market Cap: R$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

United Therapeutics

Market Cap: R$12.6b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Biogen

Market Cap: R$16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Denali Therapeutics

Market Cap: R$1.8b

Denali Therapeutics Inc., discovers, develops, and delivers barrier-crossing therapeutics for neurodegenerative, lysosomal, and other serious diseases in the United States.

Perrigo

Market Cap: R$3.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Exact Sciences

Market Cap: R$8.3b

Provides cancer screening and diagnostic test products in the United States and internationally.

IQVIA Holdings

Market Cap: R$25.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Incyte

Market Cap: R$11.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Jazz Pharmaceuticals

Market Cap: R$6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Sarepta Therapeutics

Market Cap: R$5.0b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Pfizer

Market Cap: R$124.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

CRISPR Therapeutics

Market Cap: R$3.4b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

BioMarin Pharmaceutical

Market Cap: R$10.8b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Blau Farmacêutica

Market Cap: R$2.3b

A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

GSK

Market Cap: R$52.5b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

argenx

Market Cap: R$31.1b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Exelixis

Market Cap: R$9.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Agilent Technologies

Market Cap: R$29.3b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Ultragenyx Pharmaceutical

Market Cap: R$3.2b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.